A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Researchers throw a new twist into the age-old Loch Ness Monster tale
This light-up 3-in-1 fast-charging cable is just $18
SEC to Impose New Rules for Labeling Popular Investment Funds
New Jersey utilities float solar panels on reservoir, powering water treatment plant
Startup That Lets You Instantly Talk in Foreign Language Targets a Nasdaq IPO at $1 Billion Value
Northspyre’s Real Estate Development Platform Surpasses $125 Billion in Capital Managed By Real Estate Owners and Developers
Slack to retire its status account on Elon Musk’s X
Gensler Claims More Crypto Turf in Washington as Dissent Dithers